Trial Profile
A Multicenter, Randomized, Controlled, Observer-Blinded, Dose-Response Study to Evaluate The Efficacy in Tracheal Intubation and Safety of Gantacurium Chloride for Injection in Healthy Adult Patients Undergoing Surgery with General Anesthesia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2020
Price :
$35
*
At a glance
- Drugs Gantacurium chloride (Primary) ; Suxamethonium chloride
- Indications Procedural pain
- Focus Therapeutic Use
- Sponsors Avera Pharmaceuticals
- 18 Jun 2014 New source identified and integrated; ClinicalTrials.gov record
- 18 Jun 2014 New trial record